(Note: A similarly named but unrelated Vitals RX did receive an FDA warning letter in September 2025, but it is not the same pharmacy.) Additionally, Belle received an FDA warning letter in February of 2026 and was cited for misbranding after putting Belle labels on compounded GLP-1s
But Van Zyl says that practitioners may be able to use semaglutide to bypass this metabolic hurdle (speaking hypothetically, she clarifies) by implementing weight loss consistently but gradually and with periods of plateau to allow the body time to adjust to that new weight
Xiao A, Wang J, Chen X et al
In clinical studies, Mounjaro has been shown to produce more significant weight loss than Ozempic
Im Khanyi Mbau , was a big success despite its controversial contents
Platforms like Klarity Health use a pay-per-appointment model: no upfront marketing costs, no subscription fees